Surgical Research Fellow and Consultant Colorectal Surgeon, Department of Population Medicine, School of Medicine, Cardiff University, Cardiff and Vale University Health Board, Wales, UK.
Oncology Fellow, Guy's and St Thomas' NHS Foundation Trust, London, UK.
J Gastroenterol Hepatol. 2023 Jun;38(6):854-864. doi: 10.1111/jgh.16157. Epub 2023 Mar 12.
Patients diagnosed with advanced colorectal lesions have a higher risk of developing colorectal cancer. International polyp surveillance guidelines have recently been updated. The aim of this systematic review was to assess surveillance recommendations for advanced colorectal polyps and compare the patient, polyp, and colonoscopy quality factors considered in their recommendations.
Guidelines with surveillance recommendations for colorectal polyps were identified. Databases searched included PubMed, Web of Science, Scopus, TripPro, and guidelines identified by two blinded reviewers. The review protocol was registered on PROSPERO and performed in line with PRISMA guidelines.
Six guidelines from the US Multi-Society Task Force, British Society of Gastroenterology, Cancer Council Australia, European Society of Gastrointestinal Endoscopy, Japan Gastroenterological Endoscopy Society, and Asia-Pacific Working Group on Colorectal Cancer Screening were included. The recommended surveillance interval of 3 years was consistent, but the criteria used for advanced polyps were variable. Polyp factors were the key determinant for when surveillance should be performed. Although all guidelines recognized their importance, the application of and evidence underlying patient characteristics and the quality of baseline colonoscopy were limited. All included guidelines were rated of average to high quality by the AGREE II instrument.
Surveillance guidelines for advanced colorectal polyps are of good quality but limited by their underlying evidence. Standardization of definitions would be valuable for both research and clinical application. Better knowledge of colonoscopist quality indicators and patient factors is recommended to further economize surveillance recommendations, minimize patient risk, and achieve optimal outcomes without increasing pressure on services.
诊断为晚期结直肠病变的患者发生结直肠癌的风险较高。国际息肉监测指南最近已经更新。本系统评价的目的是评估针对晚期结直肠息肉的监测建议,并比较其建议中考虑的患者、息肉和结肠镜质量因素。
确定了具有结直肠息肉监测建议的指南。搜索的数据库包括 PubMed、Web of Science、Scopus、TripPro 和由两名盲审员确定的指南。该审查方案在 PROSPERO 上进行注册,并按照 PRISMA 指南进行。
纳入了来自美国多学会工作组、英国胃肠病学会、澳大利亚癌症委员会、欧洲胃肠道内镜学会、日本胃肠病学会和亚太结直肠癌筛查工作组的 6 项指南。建议的 3 年监测间隔是一致的,但用于晚期息肉的标准是可变的。息肉因素是决定何时进行监测的关键决定因素。尽管所有指南都认识到其重要性,但患者特征和基线结肠镜检查质量的应用和证据有限。所有纳入的指南在 AGREE II 工具中的评分均为中等到高质量。
针对晚期结直肠息肉的监测指南质量较好,但受到其基础证据的限制。定义的标准化对于研究和临床应用都将是有价值的。建议进一步了解内镜医生质量指标和患者因素,以进一步优化监测建议,最大限度地降低患者风险,并在不增加服务压力的情况下实现最佳结果。